Navigation Links
Passive Smoking Makes Kids Prone To Respiratory Illness

gene are considered together, people may either have a 'GG,' 'AA' or 'AG' genotype.

The researchers found that children who had the "A" variation--either the 'AA' or 'AG' genotype--were more vulnerable to the effects of second-hand smoke.

Children with the 'A' variation who were exposed to smoke at home were 75 percent more likely to be absent from school due to illness of any kind compared to children in smoke-free homes who had the 'GG' genotype.

The effect became pronounced when it came to respiratory illness. Children with the 'A' variation who lived with two or more smokers were twice as likely to miss school due a respiratory illness compared to 'GG' children who lived in smoke-free homes. And the effect was particularly strong for lower-respiratory illness, such as chest infections. Children with the 'A' variation who were exposed to two or more smokers were four times as likely to stay home due to lower-respiratory illness than were unexposed children with the 'GG' genotype.

Chemicals found in cigarette smoke promote oxidative stress, which is involved in numerous inflammation processes in the body. TNF-alpha plays a role in those processes, and researchers suspect that variations in the TNF-alpha gene might intensify the body's inflammatory response.

(Source:ANI)
'"/>




Page: 1 2

Related medicine news :

1. Passive smoking affects respiratory system
2. Passive smoking may be harmless
3. Passive Smoking A Health Hazard Unnoticed
4. Passive Cigarette Smoking Increases Isoprostane Formation
5. Passive Immunization to prevent Bird flu infection
6. Passive smoking declared as Toxic in California
7. Passive Immunotherapy Could Prevent Avian Flu from Affecting Humans
8. Passive Smoking Worsens Allergies
9. Passive Smokers may Face Higher Heart Disease Risk
10. New hope on the Horizon for People Wishing to Quit Smoking
11. Cancers of Colon & Rectum linked to Cigarette Smoking
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Passive Smoking Makes Kids Prone Respiratory Illness

(Date:2/27/2015)... Pipette.com announces their limited time pricing ... only valid until the end of March 2015. The ... vortex mixer that allows for absolute control and true ... and is headquartered in Bohemia, New York. Scientific Industries ... as other rockers, incubators, and hybridization ovens which are ...
(Date:2/27/2015)... The V Foundation for Cancer Research, one ... excited to announce numerous promotions taking place this March. ... partnerships highlight The V Foundation’s significant work in the ... all to get involved. Awarding 100 percent of ... V Foundation has funded more than $130 million in ...
(Date:2/27/2015)... 2015 According to court documents, Donna ... June 25, 2013 and underwent a procedure during which ... mouth. Because the duodenoscope allegedly had not been ... “superbug” carbapenem-resistant Enterobacteriaceae (CRE). , A lawsuit ... County on behalf of Ms. Pirolli alleging that Lutheran ...
(Date:2/27/2015)... NY (PRWEB) February 27, 2015 Winter is ... like on human skin, exposure to snow and ice can ... can also hurt dogs’ paws. The Puppy Store is ready ... to keep their dogs safe in the winter time. , ... causing vomiting, diarrhea and other symptoms. Ingestion of ice melt ...
(Date:2/27/2015)... 2015 FACE Skincare~Medical~Wellness, a multiaward-winning ... a unique combination to take fifteen years off ... is a new treatment introduced that is the ... indicated to improve lines and wrinkles on the ... who suffers from the stubborn vertical lines between ...
Breaking Medicine News(10 mins):Health News:Pipette.com Announces Limited Time Offer of 24% Off List Price on the Vortex-Genie 2 2Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 2Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 3Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:The Puppy Store Helps Dogs Prepare for Harsh Winter Conditions 2Health News:Face Skincare Announces New Combination Therapy 2
... , , ROANOKE, Va., July ... The Virginia Psychological Association (VPA) and Virginia ... approaches to curbing this cost by awarding the 2009 VPA/VACP ... the deadline to submit nominations. , ...
... , , , ... the introduction of the newly branded Eventone Glycolic Texturizer, formerly ... U.S., including select Walgreens, HEB and CVS stores. Eventone ... by dermatologist Milton D. Moore, MD, is a breakthrough formula ...
... SPOKANE, Wash., July 23 Inland Northwest ... hold the Northwest Medical Informatics Symposium (NMIS), a health ... September 10 and 11 in Spokane, Washington. NMIS ... about the latest in health information technology. Pre-Conference Workshops ...
... , INDIANAPOLIS, July 23 ... announced that the U.S. Food and Drug Administration (FDA) has ... (rDNA origin) injection] to treat osteoporosis associated with sustained, systemic ... fracture. Glucocorticoid therapy is the most common cause of secondary ...
... Technologies, Inc. (Nasdaq: PMTI ), a leading researcher ... its quarterly conference call of its 2009 second quarter financial ... Time. If you would like to participate, please call (866) ... telephone replay will be available one hour after the call ...
... 23 Bay Area Registered nurse-turned filmmaker, David Burton, dropped ... a movie to help save lives. After seeing so ... connection between America,s food ingredients (specifically hydrogenated oil) and the ... world what he found. The movie titled "inGREEDients" is already ...
Cached Medicine News:Health News:Moore Unique Skin Care Announces the Release of Eventone Glycolic Texturizer for Men and Women 2Health News:INHS Brings Health Information Technology Conference to Spokane 2Health News:FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis 2Health News:FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis 3Health News:FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis 4Health News:FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis 5Health News:FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis 6Health News:Palomar Medical Technologies To Host Second Quarter 2009 Financial Results Conference Call and Webcast on July 30, 2009 2Health News:Nurse Turned Filmmaker Makes Lifesaving Film 2
(Date:2/27/2015)... 27, 2015 ... für kongestive Herzinsuffizienz (CHF) in seiner ersten ...     Die israelische ... Herzüberwachungssystem für Patienten mit kongestiver Herzinsuffizienz (CHF) ... ein Finanzierungsvorhaben über 5 Mio. USD abgeschlossen ...
(Date:2/27/2015)... Feb. 27, 2015  Two mass spectrometry ... applications as their effectiveness is established, according ...  Kalorama Information says that while mass spectrometry ... powerful tool in proteomic biomarker discovery and ... its traditional techniques has struggled to elucidate ...
(Date:2/26/2015)... , Feb. 26, 2015  AbbVie (NYSE: ... of studies in its neuroscience and oncology development ... 67 th American Academy of Neurology annual ... from April 18-25. The accepted abstracts feature results ... addition to investigational treatments in AbbVie,s pipeline. Presentations ...
Breaking Medicine Technology:Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7
... Shire plc (LSE: SHP, Nasdaq: SHPGY ), ... a 5-aminosalicylic acid (5-ASA) persistency analysis entitled, "Twelve-month Persistence ... Database," at Digestive Disease Week, on May 31, 2009. ... continuing patients, 20 percent of Lialda patients were continually ...
... Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN ... 1 safety and efficacy results following administration of ... with high-risk genomic factors and relapsed or refractory ... proprietary anti-CD37 Small Modular ImmunoPharmaceutical (SMIP(TM)) product candidate. ...
Cached Medicine Technology:Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 2Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 3Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 4Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 5Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL) 2Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL) 3Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL) 4Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL) 5
... The SmartCycler System is a rapid, real-time ... prepared biological samples. By automating much of ... site individually programmable, it is the fastest, ... now on the market. The SmartCycler delivers ...
... 7300 Real-Time PCR System gives you ... exceptional budget sensitivity. , , Four-color ... expression analysis, pathogen quantitation, SNP genotyping, ... controls , Powerful, versatile software ...
Opticon continuous fluorescence detector; includes optical base, analysis software, computer and monitor (this is an accessory for the DNA Engine thermal cyclers which must be ordered seperately)...
... Pathogen Identification Device) is a specialty ... responders and other rough environments. This ... technology into a portable, impact resistant ... button" use of the R.A.P.I.D. System ...
Medicine Products: